Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Record History shows a new revision entry (v3.6.5) added to replace the previous v3.6.4, indicating the study record was updated to a newer version.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe study's history now includes a new revision entry labeled v3.6.4, and the previous revision v3.6.3 is removed from the log. This reflects an update to the record's revision history rather than changes to study data.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry, v3.6.3, was added to the record history, replacing the previous v3.6.2. This reflects a site-level update to the page rather than changes to the study data.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history and the older revision (v3.6.0) was removed, updating the study record's version history.SummaryDifference0.1%

- Check72 days agoChange DetectedAdds the responsible party’s name and affiliation to the record history and introduces new metadata fields (Last verified, Last known status was, Revision: v3.6.0).SummaryDifference3%

- Check79 days agoChange DetectedThe record history now shows Revision: v3.5.5, updating from the previous v3.5.4. This reflects a new page version rather than a change to study data.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.